104 related articles for article (PubMed ID: 26200697)
1. WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience.
Madelung AB; Bondo H; Stamp I; Løvgreen P; Nielsen SL; Falensteen A; Knudsen H; Svendsen KD; Lange T; Ralfkiaer E; Nielsen K; Hasselbalch H; Thiele J
APMIS; 2015 Sep; 123(9):787-92. PubMed ID: 26200697
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience.
Madelung AB; Bondo H; Stamp I; Loevgreen P; Nielsen SL; Falensteen A; Knudsen H; Ehinger M; Dahl-Sørensen R; Mortensen NB; Svendsen KD; Lange T; Ralfkiaer E; Nielsen K; Hasselbalch HC; Thiele J
Am J Hematol; 2013 Dec; 88(12):1012-6. PubMed ID: 23897670
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.
Koopmans SM; Bot FJ; Lam KH; van Marion AM; de Raeve H; Hebeda KM
Am J Clin Pathol; 2011 Oct; 136(4):618-24. PubMed ID: 21917685
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms.
Limberger KA; Bogatyreva L; Todorova R; Herde B; Hauschke D; Pahl HL; Werner M; Aumann K
Histochem Cell Biol; 2017 Jan; 147(1):75-82. PubMed ID: 27544663
[TBL] [Abstract][Full Text] [Related]
5. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Găman M; Vlădăreanu AM; Radesi S
Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow pathology of myeloproliferative neoplasms].
Ito M
Rinsho Ketsueki; 2015 Aug; 56(8):956-62. PubMed ID: 26345553
[TBL] [Abstract][Full Text] [Related]
7. Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry.
Ng WY; Erber WN; Grigg A; Dunne K; Perkins A; Forsyth C; Ross DM
Pathology; 2024 Feb; 56(1):75-80. PubMed ID: 38071156
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Gianelli U; Iurlo A; Cattaneo D; Bossi A; Cortinovis I; Augello C; Moro A; Savi F; Castelli R; Brambilla C; Bianchi P; Primignani M; Cortelezzi A; Bosari S
Leuk Res; 2015 May; 39(5):525-9. PubMed ID: 25840747
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
Thiele J; Kvasnicka HM; Vardiman J
Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
[TBL] [Abstract][Full Text] [Related]
10. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
Seewann HL
Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
13. Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) study.
Courcoutsakis N; Spanoudaki A; Maris TG; Astrinakis E; Spanoudakis E; Tsatalas C; Prassopoulos P
J Magn Reson Imaging; 2012 Mar; 35(3):696-702. PubMed ID: 22069235
[TBL] [Abstract][Full Text] [Related]
14. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
15. An unexpected diagnosis: angiosarcoma with bone marrow involvement mimicking a myeloproliferative neoplasm.
Xie W; Lin P; Konoplev S
Br J Haematol; 2019 Feb; 184(4):495. PubMed ID: 30203835
[No Abstract] [Full Text] [Related]
16. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
17. [Myeloproliferative neoplasms and related diseases].
Kirito K
Rinsho Ketsueki; 2009 Mar; 50(3):134-46. PubMed ID: 19352079
[No Abstract] [Full Text] [Related]
18. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].
Esquivias López-Cuervo JJ; Romero Aguilar A; González García J
Sangre (Barc); 1990 Apr; 35(2):98-101. PubMed ID: 2363101
[TBL] [Abstract][Full Text] [Related]
20. [The unclassifiable myeloproliferative neoplasm--morphological, cytogenetic and clinical features].
Borovecki A; Skrtić A; Paro MM; Lasan R; Dominis M
Acta Med Croatica; 2011 Sep; 65 Suppl 1():31-6. PubMed ID: 23126027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
